JP2024519079A5 - - Google Patents
Info
- Publication number
- JP2024519079A5 JP2024519079A5 JP2023571820A JP2023571820A JP2024519079A5 JP 2024519079 A5 JP2024519079 A5 JP 2024519079A5 JP 2023571820 A JP2023571820 A JP 2023571820A JP 2023571820 A JP2023571820 A JP 2023571820A JP 2024519079 A5 JP2024519079 A5 JP 2024519079A5
- Authority
- JP
- Japan
- Prior art keywords
- triol
- ene
- ethynylandrosta
- pharmaceutical composition
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189880P | 2021-05-18 | 2021-05-18 | |
| US63/189,880 | 2021-05-18 | ||
| PCT/US2022/027294 WO2022245532A1 (en) | 2021-05-18 | 2022-05-02 | Compositions for treatment of neurodegenerative conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519079A JP2024519079A (ja) | 2024-05-08 |
| JP2024519079A5 true JP2024519079A5 (https=) | 2025-05-14 |
Family
ID=84141848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571820A Pending JP2024519079A (ja) | 2021-05-18 | 2022-05-02 | 神経変性状態の治療のための組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240108636A1 (https=) |
| EP (1) | EP4341271A4 (https=) |
| JP (1) | JP2024519079A (https=) |
| AU (1) | AU2022275684A1 (https=) |
| CA (1) | CA3218191A1 (https=) |
| MX (1) | MX2023013616A (https=) |
| WO (1) | WO2022245532A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024054452A1 (en) * | 2022-09-06 | 2024-03-14 | Biovie Inc. | Methods for the treatment of mild cognitive impairment |
| WO2025155561A1 (en) * | 2024-01-16 | 2025-07-24 | Biovie Inc. | Methods of treating long covid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070015763A1 (en) * | 2005-07-12 | 2007-01-18 | Pfizer Inc | Treatment of psychosis associated with parkinson's disease and subcortical dementias using a combination of an atypical antipsychotic with a dopamine agonist |
| DK2273994T3 (en) * | 2008-04-03 | 2016-02-01 | Neurmedix Inc | PHARMACEUTICAL FORMS OF A MEDICINE |
-
2022
- 2022-05-02 EP EP22805164.5A patent/EP4341271A4/en active Pending
- 2022-05-02 MX MX2023013616A patent/MX2023013616A/es unknown
- 2022-05-02 JP JP2023571820A patent/JP2024519079A/ja active Pending
- 2022-05-02 AU AU2022275684A patent/AU2022275684A1/en active Pending
- 2022-05-02 CA CA3218191A patent/CA3218191A1/en active Pending
- 2022-05-02 WO PCT/US2022/027294 patent/WO2022245532A1/en not_active Ceased
-
2023
- 2023-11-16 US US18/511,027 patent/US20240108636A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10912754B2 (en) | Methods and compositions for treating excessive sleepiness | |
| JP5386173B2 (ja) | 閉経前の性的欲求障害の治療のためのフリバンセリンの使用 | |
| JP2005537268A5 (https=) | ||
| JP2009536176A (ja) | 閉経後の性的欲求障害の治療のためのフリバンセリンの使用 | |
| TW200829244A (en) | Therapeutic combinations 482 | |
| JP2024519079A5 (https=) | ||
| JP2002520362A5 (https=) | ||
| RU2007123565A (ru) | Композиции разагилина, распадающиеся в ротовой полости | |
| CA2919078A1 (en) | Treatment of pruritic conditions mediated through histamine h-4 receptors | |
| JP2020533296A5 (https=) | ||
| US9226924B2 (en) | Methods of treating or preventing neuropathic pain | |
| CN104013638A (zh) | 当药黄素及其衍生物的用途 | |
| JP2021517128A (ja) | レボドパ分割用量組成物および使用 | |
| PT1628652E (pt) | Combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão | |
| CN110267657B (zh) | 氨基甲酸酯化合物用于预防、缓解或治疗震颤或震颤综合征的用途 | |
| CN110833540B (zh) | 一种柳酚咖敏片及其制备方法 | |
| EP3954374A1 (en) | Pharmaceutical combination of pimozide and methotrexate and use thereof | |
| WO2016125109A1 (en) | Pharmaceutical composition for the treatment of obesity | |
| US20050228052A1 (en) | Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine | |
| EP2783685B1 (en) | Use of levo-oxiracetam in preparation of medicines for preventing or treating coma | |
| JP3865450B2 (ja) | パーキンソニズム治療剤 | |
| Perspectivism et al. | Lofepramine (antidepressant): uses, indications and side effects | |
| US20100173879A1 (en) | Use of a compound antagonist to the nk2 receptors of neurokinin a for the preparation of drugs useful for preventing and treating of sexual dysfunction | |
| CN119523988A (zh) | 一种治疗神经系统疾病的药物组合物 | |
| CN115887462A (zh) | 一种口服药物组合物 |